CDK14 and hepatocellular carcinoma: Li et al. included HBV-related HCC TRIOS in a case–control study by the GWAS method and found that cyclin-dependent kinase 14 at 7Q21.13 (index rs10272859) was significantly associated with the susceptibility and prognosis of HBV-related HCC [27].